May 10, 2022 / 11:30AM GMT
Operator
[Welcome] to Ajanta Pharma Q4 FY22 earnings conference call. (Operator Instructions) Please note that this conference is being recorded. I now hand the conference over to Mr. Yogesh Agrawal, Managing Director of Ajanta Pharma Ltd. Thank you and over to you, sir.
Yogesh Agrawal - Ajanta Pharma Ltd. - MD
Thank you. Good evening and welcome to all of you. With me, I have Mr. Rajesh Agrawal, our Joint Managing Director and Arvind Agrawal, our CFO. I'm glad to inform you that in the financial year 2022, we have returned INR436 crores to the shareholders. We were able to get INR251 crore in the financial year 2021 in the form of dividend and buyback. So this reiterates our commitment to the shareholders to return the free cash flow in excess of the business requirements.
Further, the Board of Directors has approved in today's meeting, the issue of bonus shares in the ratio of one share for every two shares held, subject to the approval of the shareholders. Coming to the results, they are already there with you. And I'm happy to share with you, the year has
Q4 2022 Ajanta Pharma Ltd Earnings Call Transcript
Mar 20, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers